| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |